BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36252)

  • 1. Lorazepam kinetics in the elderly.
    Greenblatt DJ; Allen MD; Locniskar A; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1979 Jul; 26(1):103-13. PubMed ID: 36252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam.
    Greenblatt DJ; Divoll M; Harmatz JS; Shader RI
    J Pharm Sci; 1982 Feb; 71(2):248-52. PubMed ID: 6121043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of lorazepam. II. Intramuscular injection.
    Greenblatt DJ; Joyce TH; Comer WH; Knowles JA; Shader RI; Kyriakopoulos AA; MacLaughlin DS; Ruelius HW
    Clin Pharmacol Ther; 1977 Feb; 21(2):222-30. PubMed ID: 13960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam.
    Greenblatt DJ; Schillings RT; Kyriakopoulos AA; Shader RI; Sisenwine SF; Knowles JA; Ruelius HW
    Clin Pharmacol Ther; 1976 Sep; 20(3):329-41. PubMed ID: 8232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of oxazepam and lorazepam.
    Greenblatt DJ
    Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
    Abernethy DR; Greenblatt DJ; Ochs HR; Weyers D; Divoll M; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1983 May; 33(5):628-32. PubMed ID: 6132698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and biotransformation of lormetazepam. II. Radioimmunologic determinations in plasma and urine of young and elderly subjects: first-pass effect.
    Hümpel M; Nieuweboer B; Milius W; Hanke H; Wendt H
    Clin Pharmacol Ther; 1980 Nov; 28(5):673-9. PubMed ID: 6108174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.
    Greenblatt DJ; Allen MD; MacLaughlin DS; Huffman DH; Harmatz JS; Shader RI
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):159-79. PubMed ID: 20218012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans.
    Greenblatt DJ; Shader RI; Franke K; MacLaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E
    J Pharm Sci; 1979 Jan; 68(1):57-63. PubMed ID: 31453
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results.
    Greenblatt DJ; Comer WH; Elliott HW; Shader RI; Knowles JA; Ruelius HW
    J Clin Pharmacol; 1977; 17(8-9):490-4. PubMed ID: 19508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of lorazepam: a review.
    Kyriakopoulos AA; Greenblatt DJ; Shader RI
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):16-23. PubMed ID: 30762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam with an adjunct test of the inattention effect in humans.
    Nielsen-Kudsk F; Jensen TS; Magnussen I; Jakobsen P; Jensen PB; Mondrup K; Petersen T
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):121-7. PubMed ID: 6133404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam.
    Greenblatt DJ; Franke K; Shader RI
    J Chromatogr; 1978 Sep; 146(2):311-20. PubMed ID: 29907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative bioavailability in humans for oral tablets and solutions of lormetazepam.
    Zecca L; Reina L; Scaglione F; Ferrario P; Pirola R; Ceccarelli G; Ciampini M; Fraschini F
    Arzneimittelforschung; 1985; 35(12):1870-2. PubMed ID: 2869762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renal impairment and hemodialysis on lorazepam kinetics.
    Morrison G; Chiang ST; Koepke HH; Walker BR
    Clin Pharmacol Ther; 1984 May; 35(5):646-52. PubMed ID: 6713774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
    Abernethy DR; Greenblatt DJ; Morse DS; Shader RI
    Br J Clin Pharmacol; 1985 Jan; 19(1):51-7. PubMed ID: 2858217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cimetidine with oxazepam, lorazepam, and flurazepam.
    Greenblatt DJ; Abernethy DR; Koepke HH; Shader RI
    J Clin Pharmacol; 1984 Apr; 24(4):187-93. PubMed ID: 6144699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of intravenous and intramuscular morphine.
    Stanski DR; Greenblatt DJ; Lowenstein E
    Clin Pharmacol Ther; 1978 Jul; 24(1):52-9. PubMed ID: 657720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Lab Clin Med; 1983 Jun; 101(6):873-80. PubMed ID: 6133901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses.
    Caillé G; Spénard J; Lacasse Y; Brennan J
    Biopharm Drug Dispos; 1983; 4(1):31-42. PubMed ID: 6132630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.